(2012)() least some patients included in other reports Publication in Abstract form No information provided regarding funding and conflicts of interest AVR = aortic valve replacement; ; EuroSCORE = European System for Cardiac Operative Risk Evaluation score; SSAS = severe, symptomatic aortic stenosis Appendix 3 Summary of clinical findings for sutureless AVR Table 13: Summary of clinical findings from comparative trials of sutureless AVR Author Device Mean TV Complications All-cause mortality (n; (no. gradient patients) (mm Hg) PV leak Permanent Stroke MI Renal failure/ Bleeding In-hospital or 1-year pacemaker (severity) dialysis complications 30-day implant Concistre et al Perceval 9.1* 1%* 2 (6%) 2 (2%) NR RI: 3 (3%) NR 2 3 (2013) () S (moderate) (2.1%) (3.2%)c (n = 97) 3f Enable 11.2 16% 2 (6%) 1 (3%) NR RI: 1 (3%) NR 1 1 (n = 32) (moderate) (3.1%) (3.1%)c
(2012)() least some patients included in other reports Publication in Abstract form No information provided regarding funding and conflicts of interest AVR = aortic valve replacement; ; EuroSCORE = European System for Cardiac Operative Risk Evaluation score; SSAS = severe, symptomatic aortic stenosis Appendix 3 Summary of clinical findings for sutureless AVR Table 13: Summary of clinical findings from comparative trials of sutureless AVR Author Device (no. patients) Mean TV gradient (mm Hg) Complications All-cause mortality (n; PV leak (severity) Permanent pacemaker implant Stroke MI Renal failure/ dialysis Bleeding complications In-hospital or 30-day 1-year Concistre et al (2013) () Perceval S (n = 97) 9.1* 1%* (moderate) 2 (6%) 2 (2%) NR RI: 3 (3%) NR 2 (2.1%) 3 (3.2%)c 3f Enable (n = 32) 11.2 16% (moderate) 2 (6%) 1 (3%) NR RI: 1 (3%) NR 1 (3.1%) 1 (3.1%)c
sutureless-aortic-valve-replacement-tier3-assessment.docx